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Abstract
Background: The Israeli National and Ethnic Mutation database (http://server.goldenhelix.org/israeli) was launched
in September 2006 on the ETHNOS software to include clinically relevant genomic variants reported among Jewish
and Arab Israeli patients. In 2016, the database was reviewed and corrected according to ClinVar (https://www.ncbi.
nlm.nih.gov/clinvar) and ExAC (http://exac.broadinstitute.org) database entries. The present article summarizes some
key aspects from the development and continuous update of the database over a 10-year period, which could
serve as a paradigm of successful database curation for other similar resources.
Results: In September 2016, there were 2444 entries in the database, 890 among Jews, 1376 among Israeli Arabs,
and 178 entries among Palestinian Arabs, corresponding to an ~4× data content increase compared to when
originally launched. While the Israeli Arab population is much smaller than the Jewish population, the number of
pathogenic variants causing recessive disorders reported in the database is higher among Arabs (934) than among
Jews (648). Nevertheless, the number of pathogenic variants classified as founder mutations in the database is
smaller among Arabs (175) than among Jews (192). In 2016, the entire database content was compared to that of
other databases such as ClinVar and ExAC. We show that a significant difference in the percentage of pathogenic
variants from the Israeli genetic database that were present in ExAC was observed between the Jewish population
(31.8%) and the Israeli Arab population (20.6%).
Conclusions: The Israeli genetic database was launched in 2006 on the ETHNOS software and is available online
ever since. It allows querying the database according to the disorder and the ethnicity; however, many other
features are not available, in particular the possibility to search according to the name of the gene. In addition, due
to the technical limitations of the previous ETHNOS software, new features and data are not included in the present
online version of the database and upgrade is currently ongoing.
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Background
The Israeli population includes Jewish and Arab com-
munities, in each of which genetic disorders have been
reported in a relatively high frequency [1]. Among Jews,
the late Professor Richard Goodman compiled relatively
frequent genetic disorders and published a seminal book
“Genetic disorders among the Jewish people” [2]. On the
basis of this book, a catalog of genetic disorders in the
Jewish population was created in 1998 and later, a
catalog of genetic disorders in the non-Jewish population
in Israel was added. The data included in these two cata-
logs were updated at least once a year. In 2006, this
compilation gave rise to the Israeli National Genetic
database [3], a freely available online resource for genetic
services in Israel. This database has resulted from a
customized version of the ETHNOS software, adapted to
accommodate large datasets and to support both menu-
and keyword-based queries. Ever since, the Israeli
national and ethnic mutation database (NEMDB) has
become a useful online resource for genetic services in
Israel.
In 2016, the Israeli population included 8,556,000
citizens of whom 74.8% were Jews and 20.8% Arabs [4].
Among Israeli Arabs, 83.1% were Muslim, 9.7%
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Christian Arabs, and 7.8% Druze. The Bedouins that
have been a nomad population represent one fifth of the
Muslim Arabs and in a majority live in the Negev desert.
Jewish communities emigrated from many countries in
the world joining the Jewish population living in Israel.
While differences existed between the various regions in
Europe where the Ashkenazi Jews were living, it is diffi-
cult to distinguish subgroups among them. On the other
hand, most of the other Jewish communities remained
distinct.
Implementation
The Israeli National Genetic database (http://server.gold
enhelix.org/israeli) includes causative genomic variants
that were characterized among affected patients either
Israeli Arabs or Jews living in Israel and in the diaspora.
Palestinian Arabs living under the Palestinian Authority,
or for whom details on the exact origin were not
available, were recently added as a distinct population.
All recessive mutations are included while dominant or
X-linked mutations are recorded in the database either if
they are founder mutations, or if they were reported in
several families, or if the disorder is relatively frequent.
Since the launch of the database, each entry consists of
the name of the disorder (usually as used in the Online
Mendelian Inheritance in Man (OMIM); [https://www.
ncbi.nlm.nih.gov/omim]), the name of the gene and its
OMIM number, and the name of the mutation, whether
it was reported as a single allele, a family, several fam-
ilies or is a founder mutation. In addition, the entry
includes details on the origin of the patient if Jewish
either Ashkenazi or the country of origin and if Arab the
religion either Druze Christian or Muslim and the local-
ity of origin. The Muslim Arabs known to be Bedouins
are entered as a separate subgroup. The frequency of the
mutation in the specific population is recorded when
available.
The information included in the database is updated
according to publications in the scientific literature and
personal communications. When details needed for the
database are not included in the original report, the
authors are contacted in order to complete the data if
available. Since the end of 2010, the source of the data
was added to each new entry and when possible, this
was done also for older data.
In 2016, the entire database was reviewed and cor-
rected according to ClinVar (https://www.ncbi.nlm.nih.
gov/clinvar) and ExAC (http://exac.broadinstitute.org)
database entries. Data from ClinVar were added to the
database for each mutation including, when available,
genomic location, rs number, pathogenicity, and OMIM
reference for the mutation. The frequency in ExAC as
calculated on 60,706 unrelated individuals was added for
the variants documented in ExAC [5].
Results
Database entries
In September 2016, there were 2444 entries in the data-
base, 890 among Jews, 1376 among Israeli Arabs, and
178 entries among Palestinian Arabs. The data on Pales-
tinian Arabs are scarce since added only recently and
therefore were not included in the present analysis.
Among the 890 entries in Jews, there were 783 that were
different mutations; the other entries were cases of a
same pathogenic variant present in more than one com-
munity. There were 357 entries among the Ashkenazi
Jews, 86 entries among Moroccan Jews, 71 entries
among Iraqi Jews, 57 entries among Iranian Jews, 47
entries among Yemenite Jews, and 260 entries among
specific smaller communities. In addition, there were 98
entries in three Jewish subgroups for which details were
not available: non-Ashkenazi (38 entries), Sephardi (11
entries), or North African (21 entries) and a group of
Jews of unknown origin (28 entries). These data are
summarized in Table 1.
Among the Israeli Arabs, there were 1376 entries, 99
being duplicated since a same pathogenic variant was
reported in more than one locality in patients from a
same religious group. There were 102 unique entries
among Christian Arabs and 108 among Druze. Among
the Muslim Arabs, there were 814 unique entries with
an additional 253 entries in Muslims known to be of
Bedouin origin. Among the 1277 non-duplicated entries,
the village of origin was known in 1075 cases.
Frequency of the pathogenic variants as reported in ExAC
Among the 783 unique entries in Jews, the pathogenic
variant was present in ExAC in 247 entries (31.8%) and
the frequency of the pathogenic variant was 0.5% or more
for 44 of them (5.8%). Among the 977 unique entries in
Israeli Arabs, the pathogenic variant was present in ExAC
in 201 cases (20.6%) and the frequency of the pathogenic
variant was 0.5% or more for 22 of them (2.2%).
Details on the presence of the pathogenic variant and
their frequency in ExAC in the different Jewish and
Israeli Arab communities are given in Table 1.
Autosomal recessive disorders in the Israeli NEMDB
Subsequently, we sought to analyze the number of
pathogenic variants that were reported among patients
affected with autosomal recessive disorders among Jews
and Israeli Arabs. Among the Jews, there were 648 dif-
ferent pathogenic variants in a total of 306 different
genes, from which 192 being founder mutations (29.6%).
In 135 out of the 306 genes, more than one pathogenic
variant was reported (44.1%), and in 77 out of these
genes, at least one was a founder mutation. Among the
Israeli Arabs, there were 934 different pathogenic vari-
ants in a total of 473 different genes, 175 being founder
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mutations (18.7%). In 151 out of the 473 genes, more
than one pathogenic variant was reported (31.9%), and
in 61 out of these genes, at least one was a founder mu-
tation. The same parameters were looked for in the dif-
ferent Jewish and Israeli Arab communities, and the
data are summarized in Table 2.
Pathogenic variants present in more than one community
We then looked for pathogenic variants that were
present in more than one community. In 52 instances,
the same pathogenic variant was found among Jews
and Arabs out of which 37 variants were present in
the ExAC database (71.2%). Twenty-five out of these
37 variants (67.6%) were found in Ashkenazi Jews,
from which 23 variants were reported in the ExAC
database (92%).
In 17 instances, the same pathogenic variant was
found in geographically close Jewish communities, in-
cluding 6 among North African communities and 11
among Eastern Jewish communities. In 32 cases, the
same pathogenic variant was found in geographically
distant Jewish communities, 17 of which were docu-
mented in ExAC (53.1%). In 19 of these 32 cases, the
pathogenic variant was found in Ashkenazi Jews, 11 of
which were also documented in ExAC (57.9%).
In 16 cases, a pathogenic variant was reported in more
than one Arab religious community but not among Jews.
Among these 16 cases, 6 pathogenic variants were
reported in ExAC (37.5%).
Table 2 Autosomal recessive disorders reported in affected patients
Unique entries Number of genes Genes with >1 pathogenic varianta Founder mutationsb Founder in >1 mutationc
JEWS 648 306 135 (44.1%) 192 (29.6%) 77 (57%)
Ashkenazi 283 161 61 (37.9%) 66 (23.3%) 44 (72.1%)
Morocco 80 48 17 (35.4%) 32 (40%) 13 (76.5%)
Iraq 50 44 11 (22.9%) 23 (46%) 8 (72.7%)
Iran 62 43 3 (7%) 23 (37.1%) 3 (100%)
Yemen 37 31 4 (13.3%) 7 (18.9%) 2 (50%)
Israeli Arabs 934 473 151 (31.9%) 175 (18.7%) 61 (40.4%)
Christian 58 38 7 (17.5%) 6 (10.3%) 3 (48.3%)
Muslim 553 335 89 (26.6%) 89 (16.1%) 33 (37.1%)
Bedouins 170 140 25 (17.9%) 86 (50.6%) 20 (80%)
Druze 75 58 12(20.7%) 19 (25.3%) 7 (58.3%)
The total numbers of entries among Jews include similar entries reported in more than one community, and entries in small communities are not included in the
Table. Among Arabs, the total number of entries includes duplicated entries in which a same pathogenic variant was reported in more than one locality in
patients from a same religious group and similar entries reported in more than one community
aThe percentage in parenthesis is the number of genes with more than one pathogenic variant out of the number of genes
bThe percentage in parenthesis is the number of founder mutations out of the number of unique entries
cThe percentage in parenthesis is the number of genes with more than one founder mutation out of the number of genes with more than one pathogenic variant
Table 1 Data content statistics from the entire Israeli NEMDB
Entries Unique entries ExAC (% unique entries) ExAC >0.5 per 1000
Jews 890 783 247 (31.8%) 44 (5.8%)
Ashkenazi 357 357 136 (38.9%) 28 (7.8%)
Morocco 86 86 34 (39.5%) 8 (9.3%)
Iraq 71 71 20 (28.2%) 8 (11.7%)
Iran 57 57 19 (33.3%) 2 (2.8%)
Yemen 46 46 8 (17.0%) 1 (2.1%)
Israeli Arabs 1376 977 201 (20.6%) 22 (2.2%)
Christian 102 102 19 (18.6%) 4 (3.9%)
Muslim 814 814 151 (18.6%) 19 (2.3%)
Bedouins 253 253 36 (14.2%) 4 (1.6%)
Druze 108 108 19 (17.6%) 1 (1.9%)
The total numbers of entries among Jews include similar entries reported in more than one community, and entries in small communities are not included in the
Table. Among Arabs, the total number of entries includes duplicated entries in which a same pathogenic variant was reported in more than one locality in
patients from a same religious group and similar entries reported in more than one community
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Discussion
The technology revolution in genomic analysis changed
the ability for diagnosis and characterization of genetic
diseases in the last decades. While the late Richard M
Goodman in 1979 delineated only 11 monogenic disor-
ders relatively frequent in the Ashkenazi Jews [2], in
September 2016, founder mutations were reported in
the Ashkenazim responsible for 62 autosomal recessive
disorders, 7 dominant disorders, and one X-linked
disease. Since the creation of the Israeli NEMDB in Sep-
tember 2006, the number of database records has been
almost quadrupled. For instance, new founder mutations
were added in 36 genes among the Ashkenazi Jews in
10 years since the launch of the Israeli NEMDB.
The Ashkenazi represents the largest Jewish commu-
nity in Israel and in the diaspora, and therefore, the ob-
servation that most of the entries among Jews (63%) are
in this community was not unexpected. However, while
the Israeli Arab population is much smaller than the
Jewish population, the number of pathogenic variants
causing recessive disorders reported in the database is
higher among Arabs (934) than among Jews (648).
Nevertheless, the number of pathogenic variants classi-
fied as founder mutations in the database is smaller
among Arabs (175) than among Jews (192), which can
be explained by pathogenic variant expansion in isolated
populations.
Whole genome sequencing of random individuals and
their parents have demonstrated that every individual is
born with 44–82 de novo single-nucleotide mutations
[6], and therefore, in a defined population, many of the
newborns are carriers of new variants responsible for re-
cessive diseases. In a previous study, the fate of recessive
mutations was followed in an Israeli Muslim village in
which the families are large and close consanguinity is
frequent [7]. In this village, a new variant, occurring de
novo or being introduced by marriage of a carrier from
another village, may appear in homozygosity in a patient
already after three generations. In such isolated popula-
tions, some of the new variants spread within the kin-
dred of the first carrier, either randomly or as the result
of a selective advantage, and later may become founder
mutations within the community. A change in the mar-
riage patterns such as marriages outside of the isolate
and smaller size of the families will reduce the number
of patients affected due to founder mutations. In parallel,
some of the founder mutations that were present only in
isolated communities will appear at a lower frequency in
the whole population. Before the creation of the state of
Israel, the Jewish communities were isolated one from
the other because of geographical distances and from
the surrounding populations by the preference of mar-
riages within the religious community and often within
the family. As a result, among Jews, founder mutations
are found in the database in each of the different com-
munities. Indeed, few of these founder Jewish mutations
are present in more than one community, mainly since
they occurred before the dispersion of the Jews. For in-
stance, the mutation p.F301L in F11 which is nowadays
frequent among Ashkenazi Jews and Jews from Iraq was
probably present among Jews already 2.5 millennia ago
[8]. Among the Israeli Arabs, the preference of marriages
within the close family and within the religious commu-
nity that was responsible for their isolation is still pre-
dominant nowadays. Therefore, among the Israeli Arabs,
founder mutations are still mostly limited to single
villages or tribes. There are three exceptions in the data-
base: one is the p.T322X mutation in the ERCC8 gene
causing Cockayne syndrome that was shown to be
frequent in the entire Christian Arab community and
has been reported in Christian Arabs from Lebanon [9].
The second exception is the p.S52_G55del mutation in
the TBCE gene causing hypoparathyroidism and mental
retardation that originated among Bedouins in Saudi
Arabia who are at the origin of the Israeli Bedouin Arabs
[10]. The third exception is a mutation present in all the
Israeli Arab Bedouins p.P615Sfs*12 in the NTRK1 gene
causing congenital insensitivity to pain with anhidrosis
but has not been reported in other populations and
therefore probably occurred more recently [11]. In Israel,
many changes are occurring both in the Jewish and Arab
populations in particular of the marriage patterns that
while they remain within the religious community are
more often outside the isolate. This is particularly
frequent among Jews since consanguinity became rare
since the creation of the State of Israel and intercommu-
nity marriages became frequent [12]. Among Arabs, the
changes are slower and consanguinity is still preferred,
but marriages outside the village became more and more
frequent [13]. In both cases, these changes are expected
to scatter the founder mutations. The ultimate result
that may be expected is that some founder mutations
will remain and will become Israeli Jewish or Israeli
Arab mutations existing in each population at lower
frequency.
A significant difference in the percentage of patho-
genic variants from the Israeli NEMDB that were
present in ExAC was observed between the Jewish popu-
lation (31.8%) and the Israeli Arab population (20.6%).
The difference between the Ashkenazi Jews and the Is-
raeli Arabs was expected since the European population
including Ashkenazi Jews is better represented in ExAC
than the Middle East population [5]. However, the Jews
from Morocco, Iran, and Iraq have a percentage of
mutations present in ExAC in the same range as the
Ashkenazi Jews even though these communities origi-
nated from populations that are not well represented in
ExAC. This may in part be explained by the observation
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that several variants found among Ashkenazi Jews and
present in ExAC were also characterized in other Jewish
communities. For instance, among the 34 variants found
in Moroccan Jews that were present in ExAC, 8 were
variants that are also found among Ashkenazi Jews.
Similarly, among the mutations common to Jews and
Israeli Arabs, those reported among Ashkenazi Jews
were almost always present in ExAC (92%).
Conclusion
The Israeli NEMDB was launched in 2006 on the
ETHNOS software and is available online ever since.
It allows querying the database according to the dis-
order and the ethnicity; however, many other features
are not available, in particular the possibility to search
according to the name of the gene. In addition, due
to the technical limitations of the previous ETHNOS
software on which the Israeli NEMDB runs, new fea-
tures and data are not included on the present online
version of the database such as the source of the data,
genomic location of the variant, it rs number, and OMIM
reference or the effect of the mutation as described in the
ClinVar database. Upgrade of the Israeli NEMDB is
currently ongoing in order to include all the data de-
scribed in the article and allow new querying possibilities.
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